‎The CXCL10 has since emerged as a central player in both protective immunity ‎and pathological ‎immune responses, such as in autoimmune diseases, viral infections, ‎chronic inflammation, and ‎cancer.‎6–9‎ The interplay between the immune system and ‎cancer cells is highly dynamic, encompassing a spectrum from effective tumor elimination ‎to immune evasion.10 The immune ‎response in cancer is modulated by a complex network ‎of immune cells, signaling molecules which ‎collectively influence cancer outcomes. This evidence concerns the gene CXCL10 and autoimmune disease.